Partial breast radiation vs whole breast radiation after lumpectomy
Part of Cancer, Skin clinical trials.
This trial studies whether treating only part of the breast with radiation works as well as treating the whole breast in people with early breast cancer after lumpectomy. It may help reduce radiation exposure to healthy tissue, while still controlling the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re a woman age 50 or older
- You had breast-conserving surgery (lumpectomy), not mastectomy
- Your tumor is invasive breast cancer about under 3 cm and is one focus (not spread within the breast)
- Your cancer is not classic invasive lobular type, and it is grade 1 or 2
- Tests show lymph nodes under the arm are negative, and there is no cancer in blood/lymph vessels (no lymphovascular invasion)
- You have not had radiation to the breast or chest before, and you don’t have distant spread (no blood-borne metastases)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a shorter, more concentrated radiation schedule versus a standard shorter schedule after breast-conserving surgery. It looks at whether the treatment works well and is safe, especially for women whose lymph nodes also need radiation.
This study compares two types of radiation therapy for early-stage breast cancer after lumpectomy: radiation to just the part of the breast where the cancer was removed (partial breast) versus radiation to the whole breast. The goal is to see if partial breast radiation works just as well, with fewer side effects and a shorter treatment time.
This trial compares a shorter course of radiation focused on part of the breast versus a standard approach after lumpectomy. It aims to see if treating a smaller area can control the cancer while reducing treatment burden.
This trial compares giving radiation only to part of the breast versus not giving radiation at all after breast-conserving surgery. It’s meant for women with early, hormone-driven breast cancer to see if skipping radiation can be safe and reduce treatment burden.
This study compares two different ways of giving radiation to the breast after lumpectomy for early-stage breast cancer. It may help determine which approach controls the cancer well while reducing radiation to surrounding healthy tissue.
This trial compares two different radiation doses (30 Gy versus 26 Gy) given in five sessions after a lumpectomy to treat early-stage breast cancer. The goal is to see whether the lower dose works just as well with fewer side effects and better quality of life.
Hear when a new Malignant Neoplasm of Breast trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.